Safety of Intradermal Versus Intramuscular Administration of HIV Lipopeptides in HIV Uninfected Adult Volunteers
PHASE1CompletedINTERVENTIONAL
Enrollment
70
Participants
Timeline
Start Date
July 31, 2004
Study Completion Date
December 31, 2005
Conditions
HIV InfectionsHIV Seronegativity
Interventions
BIOLOGICAL
Lipopeptides LIPO-4
Trial Locations (1)
75014
Hopital Cochin Centre Cochin-Pasteur d'Essais vaccinaux, Paris
All Listed Sponsors
lead
French National Agency for Research on AIDS and Viral Hepatitis
OTHER_GOV
NCT00121121 - Safety of Intradermal Versus Intramuscular Administration of HIV Lipopeptides in HIV Uninfected Adult Volunteers | Biotech Hunter | Biotech Hunter